Literature DB >> 12683469

The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation.

Hans P A Van Dongen1, Greg Maislin, Janet M Mullington, David F Dinges.   

Abstract

OBJECTIVES: To inform the debate over whether human sleep can be chronically reduced without consequences, we conducted a dose-response chronic sleep restriction experiment in which waking neurobehavioral and sleep physiological functions were monitored and compared to those for total sleep deprivation.
DESIGN: The chronic sleep restriction experiment involved randomization to one of three sleep doses (4 h, 6 h, or 8 h time in bed per night), which were maintained for 14 consecutive days. The total sleep deprivation experiment involved 3 nights without sleep (0 h time in bed). Each study also involved 3 baseline (pre-deprivation) days and 3 recovery days.
SETTING: Both experiments were conducted under standardized laboratory conditions with continuous behavioral, physiological and medical monitoring. PARTICIPANTS: A total of n = 48 healthy adults (ages 21-38) participated in the experiments.
INTERVENTIONS: Noctumal sleep periods were restricted to 8 h, 6 h or 4 h per day for 14 days, or to 0 h for 3 days. All other sleep was prohibited.
RESULTS: Chronic restriction of sleep periods to 4 h or 6 h per night over 14 consecutive days resulted in significant cumulative, dose-dependent deficits in cognitive performance on all tasks. Subjective sleepiness ratings showed an acute response to sleep restriction but only small further increases on subsequent days, and did not significantly differentiate the 6 h and 4 h conditions. Polysomnographic variables and delta power in the non-REM sleep EEG-a putative marker of sleep homeostasis--displayed an acute response to sleep restriction with negligible further changes across the 14 restricted nights. Comparison of chronic sleep restriction to total sleep deprivation showed that the latter resulted in disproportionately large waking neurobehavioral and sleep delta power responses relative to how much sleep was lost. A statistical model revealed that, regardless of the mode of sleep deprivation, lapses in behavioral alertness were near-linearly related to the cumulative duration of wakefulness in excess of 15.84 h (s.e. 0.73 h).
CONCLUSIONS: Since chronic restriction of sleep to 6 h or less per night produced cognitive performance deficits equivalent to up to 2 nights of total sleep deprivation, it appears that even relatively moderate sleep restriction can seriously impair waking neurobehavioral functions in healthy adults. Sleepiness ratings suggest that subjects were largely unaware of these increasing cognitive deficits, which may explain why the impact of chronic sleep restriction on waking cognitive functions is often assumed to be benign. Physiological sleep responses to chronic restriction did not mirror waking neurobehavioral responses, but cumulative wakefulness in excess of a 15.84 h predicted performance lapses across all four experimental conditions. This suggests that sleep debt is perhaps best understood as resulting in additional wakefulness that has a neurobiological "cost" which accumulates over time.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Year:  2003        PMID: 12683469     DOI: 10.1093/sleep/26.2.117

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  708 in total

1.  Cognitive workload and sleep restriction interact to influence sleep homeostatic responses.

Authors:  Namni Goel; Takashi Abe; Marcia E Braun; David F Dinges
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

2.  The effect of one night's sleep deprivation on adolescent neurobehavioral performance.

Authors:  Mia Louca; Michelle A Short
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

3.  The maturational trajectories of NREM and REM sleep durations differ across adolescence on both school-night and extended sleep.

Authors:  Irwin Feinberg; Nicole M Davis; Evan de Bie; Kevin J Grimm; Ian G Campbell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-23       Impact factor: 3.619

4.  Reliability of a single objective measure in assessing sleepiness.

Authors:  Bernie Y Sunwoo; Nicholas Jackson; Greg Maislin; Indira Gurubhagavatula; Charles F George; Allan I Pack
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

5.  The relative contributions of the homeostatic and circadian processes to sleep regulation under conditions of severe sleep restriction.

Authors:  Gemma M Paech; Sally A Ferguson; Charli Sargent; David J Kennaway; Gregory D Roach
Journal:  Sleep       Date:  2012-07-01       Impact factor: 5.849

Review 6.  Sleep in older adults and in subjects with dementia.

Authors:  Helmut Frohnhofen; Jeanina Schlitzer; Nikolaus Netzer
Journal:  Z Gerontol Geriatr       Date:  2017-07-18       Impact factor: 1.281

7.  Psychomotor Vigilance Test and Its Association With Daytime Sleepiness and Inflammation in Sleep Apnea: Clinical Implications.

Authors:  Yun Li; Alexandros Vgontzas; Ilia Kritikou; Julio Fernandez-Mendoza; Maria Basta; Slobodanka Pejovic; Jordan Gaines; Edward O Bixler
Journal:  J Clin Sleep Med       Date:  2017-09-15       Impact factor: 4.062

Review 8.  The sleep-deprived human brain.

Authors:  Adam J Krause; Eti Ben Simon; Bryce A Mander; Stephanie M Greer; Jared M Saletin; Andrea N Goldstein-Piekarski; Matthew P Walker
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 9.  The neurobiological basis of sleep: Insights from Drosophila.

Authors:  Sarah Ly; Allan I Pack; Nirinjini Naidoo
Journal:  Neurosci Biobehav Rev       Date:  2018-01-31       Impact factor: 8.989

Review 10.  Basic sleep and circadian science as building blocks for behavioral interventions: a translational approach for mood disorders.

Authors:  Lauren D Asarnow; Adriane M Soehner; Allison G Harvey
Journal:  Behav Neurosci       Date:  2014-04-28       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.